The FTC has filed a motion of contempt against two supplement companies that, according to the motion, have continued to promote their products with false claims despite being barred from doing so by a previous court order.
Health Research Laboratories, LLC, and Whole Body Supplements, LLC, and their owner Kramer Duhon agreed to a $3.7 million judgement in 2017 after the FTC charged them with promoting the product BioTherapex with fictitious medical doctors and results from a clinical study that was actually never conducted. The companies also claimed that their product NeuroPlus could protect against Alzheimer's disease and reverse memory loss without adequate scientific evidence. A 2018 settle order also barred them from making claims about any product without at least one randomized, double-blind, placebo-controlled trial to substantiate the claim.
According to the FTC, however, the companies have violated that order by promoting other products with false claims. For example, marketing materials suggested its Ultimate Heart Formula (UHF), BG18, and Black Garlic Botanicals supplements could treat heart disease, high cholesterol and high blood pressure, and its product Neupathic was promoted as a "miraculous natural solution" to treat diabetic nerve pain.
In a news release about the FTC's most recent action against the companies, FTC Director of the Bureau of Consumer Protection Andrew Smith stated that Mr. Duhon and his companies "have a troubling history of making unproven claims that their products can treat serious diseases."
See ConsumerLab's answers to these related questions:
For other Recalls and Warnings click HERE.For information about reporting serious reactions and problems with medical products to the U.S. Food and Drug Administration through its MedWatch reporting program, please go to http://www.fda.gov/medwatch/how.htm.
Sign up for FREE Newsletter
BECOME A MEMBER
Instant Access to Reviews for OVER 1,000 Products!